Welcome to our dedicated page for Columbia Financ SEC filings (Ticker: CLBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Columbia Financial, Inc. (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank. Through these filings, investors can review detailed disclosures on the company’s financial condition, results of operations, capital management, and significant corporate events.
Columbia Financial, Inc. uses current reports on Form 8-K to announce material events. Recent 8-K filings have covered quarterly earnings releases, including financial results for periods ended March 31, June 30, and September 30, as well as the year ended December 31. These filings typically reference press releases furnished as exhibits that discuss net interest income, interest expense on deposits and borrowings, provision for credit losses, non-interest income and expense, net interest margin, and overall net income or loss.
Other 8-K filings describe corporate actions and governance matters. For example, the company has filed 8-Ks regarding authorization of a stock repurchase program to acquire up to 1,800,000 shares of common stock, including details on regulatory non-objection, permitted repurchase methods, and program terms. Additional 8-Ks disclose executive officer changes, such as the planned end date of employment for a Senior Executive Vice President and Chief Operating Officer, and the availability of investor presentations outlining operating and growth strategies.
Annual reports on Form 10-K and quarterly reports on Form 10-Q, when accessed alongside these current reports, provide comprehensive information on Columbia Financial, Inc.’s loan portfolio composition, deposit base, funding sources, balance sheet repositioning transactions, asset quality metrics, and risk factors. These filings also describe the company’s structure as a Delaware corporation and majority-owned subsidiary of Columbia Bank, MHC, and its role as the holding company for Columbia Bank, a federally chartered savings bank headquartered in Fair Lawn, New Jersey.
Stock Titan’s platform enhances these filings by delivering real-time updates from the SEC’s EDGAR system and AI-powered summaries that highlight key points from lengthy documents. Users can quickly identify important information in 10-K and 10-Q reports, track material events reported on Form 8-K, and review disclosures related to capital actions such as stock repurchase programs. Insider transaction reports on Form 4, where available, can also be monitored to see reported purchases and sales by directors and executive officers.
By combining Columbia Financial, Inc.’s official SEC filings with AI-generated insights, this page helps readers understand how the company describes its performance, strategy, and risk profile in its own regulatory disclosures.
Columbia Financial, Inc. director Robert Van Dyk reported a new stock award granted on March 12, 2026 under the company’s 2019 Equity Incentive Plan. The award will vest in one year on March 12, 2027, reflecting routine equity-based compensation rather than an open-market trade.
After this award, he reports holding 135,006 shares of common stock directly and 2,952 shares indirectly, plus fully vested and exercisable stock options covering 83,294 shares of common stock at an exercise price of $15.60 per share, expiring on July 23, 2029.
Columbia Financial, Inc. director Noel R. Holland received a stock award of Common Stock as compensation, classified as an indirect "Stock Award" holding, that will vest on March 12, 2027 under the 2019 Equity Incentive Plan.
After this grant, Holland holds 36,726 shares of Common Stock directly, plus additional indirect interests including stock-based deferral plan and SEP-IRA holdings, and 2,952 shares in stock awards. He also has fully vested and exercisable stock options covering 83,294 shares of Common Stock at an exercise price of $15.60 per share, expiring on July 23, 2029.
Columbia Financial, Inc. director Elizabeth E. Randall reported a stock award granted at a reference price of $17.43 per share under the 2019 Equity Incentive Plan, scheduled to vest on March 12, 2027. She now holds 43,141 shares of common stock directly and additional common stock indirectly through stock-based deferral, IRA, Roth IRA and stock award accounts. She also holds fully vested and exercisable stock options covering 62,474 shares of common stock at an exercise price of $15.60 per share, expiring on July 23, 2029.
Columbia Financial, Inc. director Daria Stacy-Walls reported an acquisition of common stock units through a compensation arrangement. On March 6, 2026, a trustee purchased 269.9336 phantom stock units at $18.06 each under the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. These stock unit interests will be settled in shares of stock when they are distributed to her.
Following this award, she indirectly holds 28,323.9273 common stock units through the deferral plan, directly holds 8,048 common shares, and indirectly holds 3,207 common shares through a Stock Award IV that, according to the plan terms, vests in one year on March 11, 2026.
Columbia Financial, Inc. executive vice president and chief information officer Prabhu Manesh Balachandran reported a small, non-market transaction. On a Form 4 dated for a transaction on March 6, 2026, 382 shares of common stock were withheld at $18.06 per share to cover tax obligations, leaving 5,504 common shares held directly. The filing also lists several outstanding stock option grants with exercise prices between $15.94 and $20.54 and expiration dates from 2032 through 2036, plus 7,669 phantom stock units and various indirect share holdings in company benefit and stock award plans.
Columbia Financial, Inc. executive John Klimowich reported routine compensation-related share movements. On March 6, 2026, 402 shares of common stock were withheld at $18.06 per share to cover tax obligations, a non-market disposition, and 37.9081 common shares were credited under a stock-based deferral plan at the same price.
Following these transactions, he directly holds 61,464 common shares and indirectly holds 8,337.7508 deferral-plan shares, plus additional indirect common stock through plans such as a 401(k), ESOP, SERP, and multiple stock award programs. He also retains stock options over 188,235 underlying shares at an exercise price of $15.60 expiring in 2029, along with several newer option grants over 12,030, 8,850, 20,310, and 20,227 underlying shares with exercise prices between $15.94 and $18.28 expiring between 2033 and 2036.
Columbia Financial, Inc. executive Lewis Oliver Edward Jr., SEVP & Head Commercial Banking, reported a routine tax-withholding disposition of 392 shares of common stock on March 6, 2026 at $18.06 per share. These shares were withheld to cover tax obligations rather than sold on the open market. After this transaction, he holds 27,336 common shares directly, alongside multiple stock option grants with exercise prices ranging from $15.94 to $18.28 and expirations between 2029 and 2036, all under the company’s 2019 Equity Incentive Plan.
Columbia Financial, Inc. director Noel R. Holland reported a compensation-related stock grant. On March 6, 2026, a trustee purchased 9.4364 shares of phantom stock at $18.06 per share under the Columbia Bank Stock Based Deferral Plan, raising his indirect deferral-plan interest to 10,030.3765 stock units.
Holland also reports holdings but no new trades in other positions, including 83,294 stock options with a $15.60 exercise price expiring on July 23, 2029, which are fully vested and exercisable. Additional common stock is held directly and through a SEP-IRA and Stock Award IV accounts.
Columbia Financial, Inc. President & CEO Thomas J. Kemly received an indirect award equivalent to 102.8621 shares of common stock on March 6, 2026 at $18.06 per share. The award was credited as phantom stock in a stock-based deferral plan and will be settled in shares upon future distribution. Kemly also reports significant existing direct stock option holdings with exercise prices between $15.60 and $18.28 per share and various direct and indirect common stock holdings.
Columbia Financial, Inc. executive Allyson Katz Schlesinger, SEVP & Head of Consumer Banking, reported a routine tax-withholding disposition of 428 shares of common stock at $18.06 per share on March 6, 2026. These shares were delivered to cover tax obligations, not sold in the open market. After this transaction, she directly holds 65,005 common shares and also has multiple stock option awards, including options covering 155,294 shares at an exercise price of $15.60 expiring in 2029, plus additional options with later expirations. She also reports indirect holdings through various stock-based plans and stock awards, indicating a substantial remaining equity stake in the company.